Octapharma USA Requests FDA Approval for wilate® VWD Pr

/PRNewswire/ -- Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the...

Related Keywords

Germany , United States , Lachen , Switzerland General , Switzerland , Sweden , Austria , France , Willebrand , Nordrhein Westfalen , American , Sigurd Knaub , Alit Taher , Claudia Khayat , Katerynav Vilchevska , Leonid Dubey , Sylvia Werner , Toshko Lissitchkov , Dzmitry Novik , Elina Peteva , Flemming Nielsen , Vladimir Vdovin , Adlette Inati , Margarita Arkadevna Timofeeva , Robertf Sidonio Jr , Centers For Disease , Aflac Cancer Blood Disorders Center , Octapharma Group , Emory University School Of Medicine , Drug Administration , Octapharma United States Inc , Biologics License Application Supplement , Coagulation Factor , Lyophilized Powder , Intravenous Injection , Octapharma United States President Flemming , Investigator Robert , Medical Director , Aflac Cancer , Blood Disorders Center , Associate Professor , Emory University School , Octapharma United States , Disease Control , Willebrand Disease , Ana Boban , Csongor Kiss , Plasma Derived Von Willebrand , Previously Treated Patients , Von Willebrand , Century Road , Octapharma Usa ,